Brief: Haemonetics Corp Qtrly Revenue $346 Million
07/11/2024 12:32
Nov 7 (Reuters) - Haemonetics Corp HAE.N :
* : QTRLY REVENUE $346 MILLION
* : QTRLY ADJUSTED EARNINGS PER SHARE $1.12
* : OUTLOOK 2025 ORGANIC REVENUE GROWTH 1-4%
* Q2 EARNINGS PER SHARE VIEW $1.07, REVENUE VIEW $342.6
MILLION --
LSEG IBES DATA
* FY2025 REVENUE VIEW $1.40 BILLION -- LSEG IBES DATA
Source text: ID:nPnb1y8fda
Further company coverage: HAE.N
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Haemonetics
See all newsBrief: Haemonetics Announces FDA Approval Of Perqseal® Elite Vascular Closure System
Haemonetics says FDA clears vascular closure device
US STOCKS ON THE MOVE-Palantir, Haemonetics
U.S. STOCKS ON THE MOVE-Palantir, Haemonetics, Starbucks
Haemonetics surges as CSL plans to move all US plasma centers to its devices